Jeff Yass’s Citius Pharmaceuticals, Inc. Warrant CTXRW Stock Holding History

Jeff Yass’s Portfolio CTXRW Stock Details CTXRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,871	Closed	-$2K	–	14821
2022 Q2	$2K	Buy	+15,871	New	+$3.63K	﹤0.01%	12720
2019 Q2	–	Sell	-11,049	Closed	-$3K	–	11068
2019 Q1	$3K	Buy	+11,049	New	+$3.06K	﹤0.01%	8684

Jeff Yass's CTXRW Position: Q3 2022 in Review

Jeff Yass sold out of Citius Pharmaceuticals, Inc. Warrant (CTXRW) in Q3 2022, closing a stake of 15,871 shares — an estimated $2K sold.

Jeff Yass first reported a position in CTXRW in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2019. 0 funds tracked by Wall St. Rank hold CTXRW as of Q3 2022.

Jeff Yass reported no remaining Citius Pharmaceuticals, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
Jeff Yass sold 15,871 Citius Pharmaceuticals, Inc. Warrant shares in Q3 2022, an estimated $2K.
Jeff Yass first reported a position in Citius Pharmaceuticals, Inc. Warrant in Q1 2019 and held it in 2 quarters.
Jeff Yass's Citius Pharmaceuticals, Inc. Warrant position peaked at $3K in Q1 2019.
0 funds tracked by Wall St. Rank held Citius Pharmaceuticals, Inc. Warrant as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.